Camurus AB (publ)
Stockholm Stock Exchange:CAMX.ST
Sector
Industries
Location
Market Cap
USD 4.02 B
Share Price
USD 67.64
Avg Daily Volume
149,350
Change (1 day)
-0.00%
Change (1 year)
2.76%
Change (YTD)
32.46%
Camurus AB (publ) Total Liabilities for the year ending December 31, 2023: USD 40.94 M
Camurus AB (publ) Total Liabilities is USD 40.94 M for the year ending December 31, 2023, a 37.93% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
-
Camurus AB (publ) Total Liabilities for the year ending December 31, 2022 was USD 29.68 M, a 15.71% change year over year.
-
Camurus AB (publ) Total Liabilities for the year ending December 31, 2021 was USD 25.65 M.
-
Camurus AB (publ) Total Liabilities for the year ending December 31, 2019 was USD 14.94 M.
StockViz
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%
Key Data
| Date | Total Liabilities | Shareholders' Equity | Cash and Short-Term Investments | Receivables |
|---|
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%